Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 494941 - 494960 out of 495900 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 100MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 200MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 200MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 25MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 25MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 300MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 300MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 50MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX18) avapritinib (adm: O) | AYVAKIT 50MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors | BlueprintMedicines,Corporation |
USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Cancer | Bristol-MyersSquibbCompany |
USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Cancer | Bristol-MyersSquibbCompany |
USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Cancer | Bristol-MyersSquibbCompany |
USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Cancer | Bristol-MyersSquibbCompany |
USA | (L01FD07) zanidatamab | ZIIHERA 300MG/VIAL INJ | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JazzPharmaceuticals,Inc. |